Sulfonylureas as second line treatment for type 2 diabetes

doi:10.1136/bmj.k3041

Editorial

. 2018 Jul 18:362:k3041.

doi: 10.1136/bmj.k3041.

Sulfonylureas as second line treatment for type 2 diabetes

Lucy D'Agostino McGowan¹, Christianne L Roumie²

Affiliations

¹ Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
² Veterans Health Administration-Tennessee Valley Healthcare System Geriatric Research Education Clinical Center (GRECC), and Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA christianne.roumie@vanderbilt.edu.

PMID: 30021790
DOI: 10.1136/bmj.k3041

Editorial

Sulfonylureas as second line treatment for type 2 diabetes

Lucy D'Agostino McGowan et al. BMJ. 2018.

. 2018 Jul 18:362:k3041.

doi: 10.1136/bmj.k3041.

Authors

Lucy D'Agostino McGowan¹, Christianne L Roumie²

Affiliations

¹ Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
² Veterans Health Administration-Tennessee Valley Healthcare System Geriatric Research Education Clinical Center (GRECC), and Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA christianne.roumie@vanderbilt.edu.

PMID: 30021790
DOI: 10.1136/bmj.k3041

No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: We have read and understood the BMJ policy on declaration of interests and declare: none.

Comment on

Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study.
Douros A, Dell'Aniello S, Yu OHY, Filion KB, Azoulay L, Suissa S. Douros A, et al. BMJ. 2018 Jul 18;362:k2693. doi: 10.1136/bmj.k2693. BMJ. 2018. PMID: 30021781 Free PMC article.

Cited by

Cardiovascular safety and efficacy of metformin-SGLT2i versus metformin-sulfonylureas in type 2 diabetes: systematic review and meta-analysis of randomized controlled trials.
Gebrie D, Getnet D, Manyazewal T. Gebrie D, et al. Sci Rep. 2021 Jan 8;11(1):137. doi: 10.1038/s41598-020-80603-8. Sci Rep. 2021. PMID: 33420333 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Sulfonylureas as second line treatment for type 2 diabetes

Affiliations

Sulfonylureas as second line treatment for type 2 diabetes

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical